These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 19014324)
1. The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes-The Lorenz E. Zimmerman Tribute Lecture. Sassani JW; Mc Laughlin PJ; Zagon IS J Diabetes Res; 2016; 2016():9703729. PubMed ID: 27703986 [TBL] [Abstract][Full Text] [Related]
2. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review. McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the OGF-OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat. Zagon IS; Sassani JW; Purushothaman I; McLaughlin PJ Exp Biol Med (Maywood); 2020 Sep; 245(15):1414-1421. PubMed ID: 32640891 [TBL] [Abstract][Full Text] [Related]
4. Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity. Chen X; Jian D; Xing J; Cheng X; Wang C; Wang C; Pan J; Qi X; Wang S; Li Z; Liu Y; Jian L; Tang H Free Radic Biol Med; 2024 Oct; 223():398-412. PubMed ID: 39122201 [TBL] [Abstract][Full Text] [Related]
5. Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin. Purushothaman I; Zagon IS; Sassani JW; McLaughlin PJ Biochem Pharmacol; 2021 Oct; 192():114712. PubMed ID: 34324868 [TBL] [Abstract][Full Text] [Related]
6. The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer. Hankins GR; Harris RT Adv Neurobiol; 2024; 35():45-85. PubMed ID: 38874718 [TBL] [Abstract][Full Text] [Related]
8. Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Ciwun M; Tankiewicz-Kwedlo A; Pawlak D Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539570 [TBL] [Abstract][Full Text] [Related]
9. Next Generation Sequencing and Association Studies in Familial Nonmedullary Thyroid Carcinoma: Let's Choose Appropriate Controls. Cazabat L; Terray A; de Mazancourt P; Ropers J; Groussin L; Raffin-Sanson ML Eur Thyroid J; 2017 Jul; 6(4):221-224. PubMed ID: 28868263 [No Abstract] [Full Text] [Related]
10. Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy. Wang R; Zhang Y; Shan F Int Immunopharmacol; 2019 Oct; 75():105785. PubMed ID: 31404891 [TBL] [Abstract][Full Text] [Related]
12. Opioid growth factor and the treatment of human pancreatic cancer: a review. Zagon IS; McLaughlin PJ World J Gastroenterol; 2014 Mar; 20(9):2218-23. PubMed ID: 24605021 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Budka J; Debowski D; Mai S; Narajczyk M; Hac S; Rolka K; Vrettos EI; Tzakos AG; Inkielewicz-Stepniak I Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399336 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the growth of human melanoma cells by methionine enkephalin. Wang DM; Wang GC; Yang J; Plotnikoff NP; Griffin N; Han YM; Qi RQ; Gao XH; Shan FP Mol Med Rep; 2016 Dec; 14(6):5521-5527. PubMed ID: 27878237 [TBL] [Abstract][Full Text] [Related]